Nanosphere Health Sciences Inc
CNSX:NSHS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nanosphere Health Sciences Inc
CNSX:NSHS
|
US |
|
China Citic Bank Corp Ltd
OTC:CHBJF
|
CN |
|
C
|
CO2 GRO Inc
OTC:BLONF
|
CA |
|
First Atlantic Nickel Corp
XTSX:FAN
|
CA |
|
D
|
Dexin Services Group Ltd
HKEX:2215
|
CN |
|
E
|
Ever Gotesco Resources and Holdings Inc
XPHS:EVER
|
PH |
|
K
|
Khon Kaen Sugar Industry PCL
SET:KSL
|
TH |
|
Rli Corp
NYSE:RLI
|
US |
|
Enstar Group Ltd
NASDAQ:ESGR
|
BM |
|
P
|
PSMC Co Ltd
KOSDAQ:024850
|
KR |
|
P
|
Perak Transit Bhd
KLSE:PTRANS
|
MY |
|
Sensus Healthcare Inc
NASDAQ:SRTS
|
US |
|
ABR Holdings Ltd
SGX:533
|
SG |
|
C
|
Creative & Innovative System Corp
KOSDAQ:222080
|
KR |
|
A
|
Alior Bank SA
WSE:ALR
|
PL |
|
DREAM Unlimited Corp
TSX:DRM
|
CA |
|
Hitachi Construction Machinery Co Ltd
OTC:HTCMF
|
JP |
|
I
|
INITECH Co Ltd
KOSDAQ:053350
|
KR |
|
C
|
Central China Securities Co Ltd
HKEX:1375
|
CN |
|
N
|
Ngai Hing Hong Co Ltd
HKEX:1047
|
HK |
|
B
|
BSF Enterprise PLC
LSE:BSFA
|
UK |
|
United Fire Group Inc
NASDAQ:UFCS
|
US |
|
B
|
Berjaya Philippines Inc
XPHS:BCOR
|
PH |
Multiples-Based Value
The Multiples-Based Value of one NSHS stock under the Base Case scenario is hidden CAD. Compared to the current market price of 0.02 CAD, Nanosphere Health Sciences Inc is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
NSHS Competitors Multiples
Nanosphere Health Sciences Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
N
|
Nanosphere Health Sciences Inc
CNSX:NSHS
|
205.5k CAD | 0 | 0.5 | -1.1 | -1.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.4 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP | 5.2 | 29.7 | 16.4 | 23.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GSK plc
XETRA:GS71
|
99.8B EUR | 2.7 | 15.2 | 8.2 | 10.2 |